Filippo Conti Selected Research

Sepsis (Septicemia)

5/2023	Monocyte HLA-DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds.
1/2023	Identification of a sub-group of critically ill patients with high risk of intensive care unit-acquired infections and poor clinical course using a transcriptomic score.
3/2022	Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.
1/2022	A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19.
1/2022	Mortality Prediction in Sepsis With an Immune-Related Transcriptomics Signature: A Multi-Cohort Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Filippo Conti Research Topics

Disease

6	Critical Illness (Critically Ill) 01/2023 - 11/2021
6	COVID-19 04/2022 - 11/2021
5	Sepsis (Septicemia) 05/2023 - 01/2022
3	Neoplasms (Cancer) 01/2012 - 09/2006
1	Infections 01/2023
1	Lymphopenia (Lymphocytopenia) 04/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Wounds and Injuries (Trauma) 12/2021
1	Retinoblastoma (Glioblastoma, Retinal) 01/2012
1	Carcinogenesis 01/2012
1	Glioblastoma (Glioblastoma Multiforme) 12/2010
1	Prostatic Diseases 12/2009
1	Inflammation (Inflammations) 12/2009
1	Fibrosis (Cirrhosis) 12/2009
1	Adenocarcinoma 12/2009
1	Alzheimer Disease (Alzheimer's Disease) 05/2008
1	Hepatocellular Carcinoma (Hepatoma) 11/2006
1	Colonic Neoplasms (Colon Cancer) 09/2006

Drug/Important Bio-Agent (IBA)

3	HLA-DR Antigens (HLA-DR)IBA 05/2023 - 12/2021
3	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2022
3	indolepropanol phosphate (IPP)IBA 01/2023 - 01/2022
3	Interleukin-7 (Interleukin 7)IBA 04/2022 - 01/2022
1	5-aminodaunorubicin (DR 22)IBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	InterferonsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Immunoglobulin Fc FragmentsIBA 01/2022
1	CytokinesIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 11/2021
1	Immunoglobulin G (IgG)IBA 11/2021
1	Immunoglobulin M (IgM)IBA 11/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2012
1	triflorcasIBA 01/2012
1	NucleophosminIBA 01/2012
1	benzothiazoleIBA 01/2012
1	JLK 1486IBA 12/2010
1	AminesIBA 12/2010
1	Protons (Proton)IBA 12/2009
1	Amyloid beta-PeptidesIBA 05/2008
1	Culture MediaIBA 11/2006
1	Proteins (Proteins, Gene)FDA Link 09/2006
1	Cytostatic AgentsIBA 09/2006

Therapy/Procedure

1	Therapeutics 01/2023
1	Precision Medicine 01/2023
1	Immunomodulation 03/2022
1	Molecular Targeted Therapy 01/2012